baber/WOPTO huggingface dataset:
Patent DK-0410604-T3 (DK)
Inventor: DASINGER BRUCE L
IPC: C09K23/56
Filed: 1990-07-11
Granted: 1994-05-02
Abstract: Heteropolysaccharide 105-4, prepared by fermentation of a new, unnamed Pseudomonas species ATCC 53923 is useful as an industrial thickening, suspending or stabilizing agent.
Patent DK-0420393-T3 (DK)
Inventor: YOLTON CHARLES F
IPC: B22F9/08
Filed: 1990-07-16
Granted: 1994-10-24
Abstract: A system and method for atomizing a titanium-based material to particulates in a controlled atmosphere. The system includes a crucible (30) for skull melting a titanium-based material. The molten titanium-based material is transferred to a tundish (40) for receiving the molten titanium-based material. The tundish has a bottom portion with an aperture formed therein and is heated. A molten metal nozzle for forming the molten titanium-based material into a free-falling stream exiting from the tundish is provided, the molten metal nozzle being coaxially aligned with the aperture of the tundish. A baffle may be disposed in the tundish for stabilizing the free-falling stream of the molten titanium-based material. The molten titanium-based material is atomized by impinging the free-falling stream of the molten titanium-based material with an inert gas jet issuing from a gas nozzle (50). The system also includes a device (60) for cooling the atomized titanium-based material, and a device for collecting the cooled atomized titanium-based material. In the method, titanium is skull melted in a crucible. The molten titanium-based material is transferred to a heated tundish. The molten titanium-based material may be stabilized in the heated tundish and then formed into a free-falling stream. The free-falling stream of the molten titanium-based aterial is impinged with an inert gas jet to atomize the molten titanium-based material. The method also includes cooling the atomized titanium-based material, and collecting the cooled atomized titanium-based material.
Patent DK-0435749-T3 (DK)
Inventor: GEORGE PASCAL
IPC: A61P9/12
Filed: 1990-12-20
Granted: 1996-05-20
Abstract: Compounds of general formula (I) 
<IMAGE>
 in which n represents the number 2, 3, 4 or 5, p represents the number 0 or 1, R1 represents a hydrogen atom or a methyl group, Xm represents one or more atoms or groups chosen from the following: hydrogen, fluorine, chlorine, methoxy, isopropyl or cyclopropyl, in the form of free bases or of addition salts with acids. 
<??>Use in therapy.
Patent DK-0465875-T3 (DK)
Inventor: DUDITS DENES DR
IPC: A01H5/10
Filed: 1991-06-18
Granted: 1999-08-09
Abstract: Protoplasts which regenerate reproducibly in a short time to normal, fertile plants can be regenerated from an auxin-autotrophic genotype of Zea mays (L.).
Patent DK-0594574-T3 (DK)
Inventor: FABRY BERND DR
IPC: C09K23/08
Filed: 1990-12-07
Granted: 1995-11-06
Abstract: Aqueous solutions of alkaline, alkaline earth, ammonium and/or amine salts of sulphonated fatty acid glycerine esters are obtained by converting fatty acid glycerine esters with iodine numbers lower than 5 with gaseous sulphur trioxide in reactors operating on the continuous falling film principle followed by neutralisation with aqueous bases and are suitable for the manufacture of surface-active agents.
Patent DK-0485563-T3 (DK)
Inventor: SINN HANS-J
IPC: A61K47/48
Filed: 1991-05-29
Granted: 1995-03-20
Abstract: Substances for treating or diagnosing tumours, with preferred concentration in the tumor, are characterized in that they have at least two phenolic hydroxyl and/or amino groups, at least one aliphatic amino group, or at least one phenolic hydroxyl and/or amino group and at least one aliphatic amino group, and these groups are substituted with polyethylene glycol chains, whose degree of polymerization n is 5 to 250 and whose terminal hydroxyl group is substituted by C1?-C12? alkyl ester or ether, each substance being substituted by at least two such polyethylene glycol chains.
Patent DK-0544716-T3 (DK)
Inventor: MIRABELLI CHRISTOPHER K
IPC: C12Q1/68
Filed: 1991-07-23
Granted: 2003-03-17
Abstract: Compositions and methods are provided for the treatment and diagnosis of diseases amenable to treatment through modulation of the synthesis or metabolism of intercellular adhesion molecules. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with nucleic acids encoding intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial leukocyte adhesion molecule-1. The oligonucleotide comprises nucleotide units sufficient in identity and number to effect said specific hybridization. In other preferred embodiments, the oligonucleotides are specifically hybridizable with a transcription initiation site, a translation initiation site, 5'-untranslated sequences, 3'-untranslated sequences, and intervening sequences. Methods of treating animals suffering from disease amenable to therapeutic intervention by modulating cell adhesion proteins with an oligonucleotide or oligonucleotide analog specifically hybridizable with RNA or DNA corresponding to one of the foregoing proteins are disclosed. Methods for treatment of diseases responding to modulation cell adhesion molecules are disclosed.
Patent DK-0542903-T3 (DK)
Inventor: KUHAR MICHAEL J
IPC: C07F7/22
Filed: 1991-08-09
Granted: 1997-04-21
Abstract: PCT No. PCT/US91/05553 Sec. 371 Date Mar. 23, 1993 Sec. 102(e) Date Mar. 23, 1993 PCT Filed Aug. 9, 1991 PCT Pub. No. WO92/02260 PCT Pub. Date Feb. 20, 1992.3 beta -[4-iodophenyl]-tropan-2 beta -carboxylic acid methyl ester tartrate is a high affinity binding ligand for cocaine receptors in mammalian brains. It and its congeners may be employed for imaging and other brain scanning techniques that allow the determination of the presence of cocaine receptors, such as dopamine and serotonin transporters and the like.
Patent DK-0498281-T3 (DK)
Inventor: TAKAHASHI MASAAKI
IPC: A61B5/0285
Filed: 1992-01-29
Granted: 1996-04-01
Abstract: An apparatus for measuring a transmission velocity of a pulse wave includes a sensor 1 for sensing heart sounds, and pulse wave signals at the upstream and downstream side of a blood flow, an analog to digital conversion unit 2, a data processing unit 3, and a display unit 4. The data processing unit 3 includes a first processor for detecting the first heat sound and generating a marker signal, second and third processors for transforming the received signals for a display thereof, a fourth processor responsive to the signals from the first, second, and third processors for detecting the marker signal and obtaining predetermined data from the data received, a fifth processor for receiving signals from the second and third processors and temporarily storing the received signals, a sixth processor for receiving signals from the fourth processor and measuring the transmission time of the pulse wave to derive the transmission velocity of the pulse wave, and a seventh processor for receiving the signal from the sixth processor and transforming the received signal for a display thereof. <IMAGE>
Patent DK-0504840-T3 (DK)
Inventor: HETTICH BERNHARD DR
IPC: C01G1/00
Filed: 1992-03-18
Granted: 1998-05-25
Abstract: The invention relates to an oxide-ceramic superconducting material which contains bismuth, strontium, calcium and copper, having an overall composition of BiyCa2Sr2Cu3Ox, where y is an integer from 2.35 to 2.6 and x is about 10 to 12. The material has a critical temperature T above 105 K and has a proportion of the phase Bi2Sr2Ca2Cu3Ox of at least 85% by volume. The invention also relates to a process for producing a bismuth-containing superconducting material which comprises holding the oxides or oxide precursors of bismuth, strontium, calcium and copper at a temperature in the range from 850 DEG  to 890 DEG  C. over a time span of a plurality of hours and adhering to the following atomic ratios: Bi:Cu>2:3 Ca:Sr=0.9 to 1.50  SIGMA (Sr+Ca):Cu=4.2:3 to 4:3.33 Bi: SIGMA (Sr+Ca)=2.35:4 to 3.1:4
Patent DK-0577867-T3 (DK)
Inventor: CAMPS AN JOSEPHA MARIA
IPC: B65D5/74
Filed: 1992-07-06
Granted: 1996-05-06
Abstract: The invention relates to laminate material containers having a push-in opening in the form of a flap door (40). The flap door (40) is formed in the laminate material by removing the structural stability layer (36) from the laminate material on three sides of the flap door (40) and keeping the fourth side intact as a hinge (42). Outer barrier layers (32,34) on each side of the structural stability layer (36) are joined to each other (44) where the stability layer has been removed. The flap door (40) is pushed-in by a lever (20) which is cantilevered on one side in a pouring aperture of a reclosable opening member (10). The push-in lever (20) has a recess (22) along its side into which the flap door (40) engages upon initial opening and thereby remains permanently open. Due to the barrier layers (32,34) being laminated across the removed structural stability layer (36), the structural stability layer (36) is not exposed to liquid or humidity preventing it from softening and obstructing the opening aperture. <IMAGE>   <IMAGE>
Patent DK-0513881-T3 (DK)
Inventor: DESROSIERS VICTOR J
IPC: D06B23/04
Filed: 1992-03-09
Granted: 1996-10-14
Abstract: A dye tube (10) for use in dyeing textile yarns has a generally open-ended, cylindrical configuration with a latticed side wall. It includes longitudinal stabilizing elements (28) to prevent growth or collapse during high-speed winding operations. In turn, these longitudinal stabilizing elements buckle and collapse when the dye tube as a whole is compressed in a longitudinal direction in a spring tube application. The longitudinal stabilizing elements may be disposed in pairs separated by a gap, or singly. In the latter case, a longitudinal groove may be provided along the length of the element; the element will split along this groove when the tube is compressed. In either case, this provides a means for dye to pass through that portion of the tube during use in a dyeing operation. The longitudinal stabilizing elements can resemble thin membranes in appearance, the membranes being of greater width than thickness. In yet another case, the longitudinal stabilizing element may cover the entire inner surface of a dye tube. The longitudinal stabilizing elements may be incorporated in helical, and other kinds of, dye tubes known in the art. <IMAGE>
Patent DK-0561095-T3 (DK)
Inventor: SANZ ARAPILES JESUS
IPC: B61B7/06
Filed: 1992-12-31
Granted: 1996-12-09
Abstract: This system of overhead transport consists essencially of a track with two rail-cables (2), horizontally placed, along which the motorised vehicles(1) run and are electrically powered. These cables are maintened statically parallel by cable-carrier shoes (5) attached to the ends of fixtures (21/28) hanging firmly from support arms (22) with support pillars (20) or from a third horizontalizing cable (25) supported in (24). The rail cables are drawn with hydraulic cylinders (51/55) from the pillars where a cable ends and another begins. To make the vehicle passing through them smoothly, the cable-carrier shoes begin in a slended way (50a) under every cable and go step by step widening and joining it until they form two horizontal planes (53) where the traction wheels (31) of the vehicle roll. This widening of the shoes also force the guide-arms (41) to open through the wheels (43). <IMAGE>
Patent DK-0567505-T3 (DK)
Inventor: WALLIS ROGER
IPC: B22D41/14
Filed: 1992-01-14
Granted: 1996-12-23
Abstract: PCT No. PCT/GB92/00080 Sec. 371 Date Jul. 6, 1993 Sec. 102(e) Date Jul. 6, 1993 PCT Filed Jan. 14, 1992 PCT Pub. No. WO92/12815 PCT Pub. Date Aug. 6, 1992A rotary valve for use in the release of a molten solid from a vessel comprises a valve member having a passage, inlets to the passage being present in the head of the member. The valve member mates with a wall of a seating member, the wall having a taller first section and a lower second section selected to close off or open the inlets, respectively. The wall portions are shaped relative to the surfaces of the member to avoid metal freezing and the parts sticking. The passage includes ribs to cause the stream to emerge with parallel sides.
Patent DK-0570593-T3 (DK)
Inventor: KAGEYAMA BUNJI
IPC: C12P41/00
Filed: 1992-12-04
Granted: 1999-02-15
Abstract: A process for producing optically active norborneol comprising the step of bringing a (+/-)-exo-norbornane type ester represented by formula (I) into contact with a microorganism, which may be optionally treated, selected from among those belonging to the genera Pseudomonas, Acetobacter, Arthrobacter, Rhodotorula and Saccharomyces. A simple post-treatment of the product gives rise to highly pure (+)- and/or (-)-exo-norbornane type alcohol in high yields.
Patent DK-0564093-T3 (DK)
Inventor: WONG SAMUEL SIU-MING
IPC: A61K31/505
Filed: 1993-02-26
Granted: 2000-03-27
Abstract: This invention relates to the use of certain hydroxylated metabolites and derivatives of doxazosin and their pharmaceutically acceptable acid addition salts for retarding the development of atherosclerosis in a mammal. Such compounds are useful for reducing atherosclerotic plaque involvement and for retarding and reducing both lipid deposition fibrosis in the development of atherosclerotic plaques.
Patent DK-0647301-T3 (DK)
Inventor: COUTTS GRAEME FORBES
IPC: E21B34/00
Filed: 1993-05-27
Granted: 1999-08-30
Abstract: PCT No. PCT/GB93/01110 Sec. 371 Date Mar. 13, 1995 Sec. 102(e) Date Mar. 13, 1995 PCT Filed May 27, 1993 PCT Pub. No. WO94/00709 PCT Pub. Date Jan. 6, 1994.A pressure relief valve includes an apertured ball valve element which is spring loaded and is rotatably and axially mounted in the valve bore so that when an over pressure situation arises fluid forces the ball axially off the valve seat against the force of a spring and causes the ball valve to rotate such that the aperture in the ball valve connects the inlet bore and outlet bore of the valve housing so that fluid can flow through the pressure relief valve. When pressure at the inlet falls beneath a predetermined value, the spring forces the ball to rotate and move back against the valve seat, thus closing the valve. With this arrangement there is minimal pressure exerted on the valve housing and the valve will operate with a back pressure up to 50% of the inlet pressure. This means that much smaller bore outlet piping can be used with a savings in weight and, consequently, cost.
Patent DK-0714393-T3 (DK)
Inventor: KLEINMAN EDWARD F
IPC: A61K31/425
Filed: 1994-05-19
Granted: 1999-02-22
Abstract: PCT No. PCT/IB94/00113 Sec. 371 Date Jan. 11, 1996 Sec. 102(e) Date Jan. 11, 1996 PCT Filed May 19, 1994 PCT Pub. No. WO95/05378 PCT Pub. Date Feb. 23, 1995Compounds of formula (I) are active antiviral compounds useful in the treatment of viral infections in mammals. The compounds of the invention are readily prepared by reaction of a suitable 2-thiothiazole derivative with an appropriate Het-(CH2)n-halide.
Patent DK-0711375-T3 (DK)
Inventor: DOLMAN TERENCE JAMES
IPC: E05C9/20
Filed: 1994-07-26
Granted: 1997-10-13
Abstract: PCT No. PCT/GB94/01601 Sec. 371 Date Jan. 19, 1996 Sec. 102(e) Date Jan. 19, 1996 PCT Filed Jul. 26, 1994 PCT Pub. No. WO95/03463 PCT Pub. Date Feb. 2, 1995A shoot bolt mechanism includes a casing having a front wall and a rear wall. The casing contains a shoot bolt having opposed ends and slidable between an inoperative and an operative position. A rotatable drive member is mounted in the casing adjacent the casing rear wall. A link is pivotally connected at one end to the shoot bolt and at another end to the drive member at a point eccentric from an axis of rotation of the drive member. Rotation of the drive member is translated by the link into movement of the shoot bolt between retracted and extended positions. Two drive transfer members are disposed on respective opposite sides of the shoot bolt between opposed ends thereof when the shoot bolt is in the retracted position. Rotation of the drive member moves the drive transfer members between respective retracted and extended positions in directions generally normal to the direction of movement of the shoot bolt between its retracted and extended positions.
Patent DK-0716797-T3 (DK)
Inventor: LEIH GEORGE
IPC: H04W8/20
Filed: 1994-08-31
Granted: 1997-09-22
Abstract: The invention relates to a system for mobile communication, comprising a mobile station (1) and a communication domain (A) with at least one base station, which communication domain (A) overlaps, at least in part, another communication domain (B) in a certain area (C), as a result of which there are available to the mobile station (1), in the said area (C), a plurality of communication domains (A, B). The system is arranged for selecting, on the basis of a preference list, an available communication domain. According to the invention, the system supports a plurality of services, a separate preference list being provided for each user and for each service supported. Preferably, the selection takes place automatically and is periodically checked.
Patent DK-0665311-T3 (DK)
Inventor: SCHRELL ANDREAS DR
IPC: D01F2/04
Filed: 1995-01-11
Granted: 1999-08-16
Abstract: Aminated cellulosic synthetic fibres are obtd. by adding an amine-substd. cellulose deriv. (II) to a viscose material or alkali cellulose (III) and processing by the viscose spinning method, or by adding (II) to a cellulose soln. and spinning to give fibres. (II) consists of polymers of unsatd. amines with cellulose or cellulose components (2), or reaction prods. of (2) with amines of formula (1a) or (1b): Y = ester gp.; A + N + one or two 1-4C alkylene gps. = bivalent heterocyclic gp.; A = O or a gp. of formula R-N, R-CH or Z-R1R2N+; R = H, amino, 1-6C alkyl (opt. substd. with 1 or 2 amino, sulpho, OH, sulphato, phosphato or COOH gps.) or 3-8C alkyl with 1 or 2 in-chain O and/or NH gps. (opt. substd. with one gp. as above, except phosphato); R1, R2 = H, Me or Et; Z = anion; B = -NH2, R1R3N- or Z- R1R2R4N+-; R3 = Me or Et; R4 = H, Me or Et; alkylene = 2-6C alkylene (opt. substd. with 1 or 2 OH) or 3-8C alkylene with 1 or 2 in-chain O and/or NH; alk = 2-6C alkylene, or 3-8C alkylene with 1 or 2 in-chain O and/or NH, pref. 2-6C alkylene; m = 1 or 2; n = 1-4; the amino, OH and ester gps. can be on prim., sec. or tert. C atoms of the alkylene gp. Also claimed is a process for the prodn. of dyed or printed cellulosic synthetic fibre materials, by producing the aminated fibres as above, converting into woven or knitted fabric, and dyeing or printing this with reactive dye(s), pref. at pH 4.5-8.5, in the absence of electrolyte salts or alkali.
Patent DK-0703232-T3 (DK)
Inventor: SHUTSKE GREGORY
IPC: C07D401/04
Filed: 1995-08-07
Granted: 2004-10-04
Abstract: 2,3-dihydro-1H-isoindole derivatives of the formula (I) <CHEM> where R1-R5 and X are as defined herein and a process for their preparation are disclosed. The compounds are useful as serotonin reuptake inhibitors and, as such, may be useful for the treatment of depression, obsessive-compulsive disorders, stuttering and trichotillomania.
Patent DK-0710719-T3 (DK)
Inventor: JAKOBOVITS AYA
IPC: C07K14/00
Filed: 1991-01-11
Granted: 2007-07-09
Abstract: The subject invention provides non-human mammalian hosts characterized by inactivated endogenous Ig loci and functional human Ig loci for response to an immunogen to produce human antibodies or analogs thereof. The hosts are produced by repetitive transformations of embryonic stem cells by homologous recombination, preferably in conjunction with breeding. Different strategies are employed for recombination of the human loci randomly or at analogous host loci.
Patent DK-0842668-T3 (DK)
Inventor: KOCH LOTHAR
IPC: A61K51/10
Filed: 1996-11-15
Granted: 2003-01-06
Abstract: This invention relates to an ex-corpore method of treating human blood cells incorporating tumour cells particularly in the frame of High-Dose Chemotherapy and/or Total Body Irradiation. According to the invention,   a) carriers selective for specific tumour cells are conjugated to radionuclides which emit short range alpha particles with high linear energy transfer, forming a radio-immunoconjugate, b) a filtration/separation step is performed on the radio-immunoconjugate ensuring the removal of non-conjugated radionuclides, c) stem cells extracted from said blood and/or bone marrow, extracted from a patient for autologous transplant, are mixed ex-corpore with said conjugated radionuclides, d) after an incubation period a purging of the blood cells and/or bone marrow is performed.   <IMAGE>
Patent DK-0802975-T3 (DK)
Inventor: MARQUET MAGDA
IPC: B01J20/14
Filed: 1996-01-03
Granted: 2003-07-14
Abstract: The invention relates to a process for reducing RNA concentration in a mixture of biological material, comprising the steps of: (a) providing a mixture of biological material having a first concentration of RNA; (b) filtering the mixture through a diatomaceous earth material to produce a filtrate having a second concentration of RNA, wherein the second concentration is less than the first concentration; and (c) collecting the filtrate having a reduced RNA concentration. In one aspect, the diatomaceous earth material serves to purify recombinant plasmid DNA from an RNA component in a mixture of biological material, and in another aspect, it serves to separate different forms of soluble RNA in a mixture of biological material.
Patent DK-0862563-T3 (DK)
Inventor: BOMBARDELLI EZIO
IPC: A61K31/335
Filed: 1996-05-08
Granted: 2000-10-30
Abstract: PCT No. PCT/EP96/01919 Sec. 371 Date Aug. 5, 1997 Sec. 102(e) Date Aug. 5, 1997 PCT Filed May 5, 1996 PCT Pub. No. WO96/36622 PCT Pub. Date Nov. 21, 1996The present invention relates to novel 10-deacetyl-14 beta -hydroxybaccatine III derivatives. The novel derivatives, having cytotoxic and antitumour activity, are prepared from this synton after functionalization of the hydroxyls at 1-, 14- as thiocarbonate, iminocarbonate and sulfite and possible oxidation of the hydroxyl at C10. These derivatives are subjected to a subsequent esterification at position 13- with a variously substituted isoserine chain. The products of the invention can be administered by the injective or oral route, when suitably formulated.
Patent DK-0832094-T3 (DK)
Inventor: ZASLOFF MICHAEL
IPC: C07J41/00
Filed: 1996-06-07
Granted: 2004-05-17
Abstract: Aminosterol compounds are described that are useful as inhibitors of the sodium/proton exchanger (NHE). Methods of using such aminosterols compounds are also enclosed, including those employing compounds that are inhibitors of a spectrum of NHEs as well as those using compounds that are inhibitors of only one specific NHE. Advantageous screening techniques and essays for evaluating a compound's therapeutic activity are also disclosed.
Patent DK-0839059-T3 (DK)
Inventor: COMAZZI VERONIQUE
IPC: A61K51/04
Filed: 1996-07-16
Granted: 2002-08-12
Abstract: PCT No. PCT/FR96/01103 Sec. 371 Date Jan. 16, 1998 Sec. 102(e) Date Jan. 16, 1998 PCT Filed Jul. 16, 1996 PCT Pub. No. WO97/03705 PCT Pub. Date Feb. 6, 1997The present invention relates to cardiac tropism radiopharmaceutical products incorporating a nitride complex os a transition metal and having a rapid myocardial clearance. These complexes are based on the formula:(M 3BOND N)L1L2 (I)in which M is a transition metal such as 99mTc and L1 and L2 comply with the formula: in which at least one of the R and R' represents a branched alkyl group having one or more ether functions, a tetrahydrofurfuryl or ether group, a tetrahydrofurfuryl or dioxaspiro or dialkoxy piperidino groups.
Patent DK-0868188-T3 (DK)
Inventor: ENDRIKAT JAN
IPC: F16J15/00
Filed: 1996-12-20
Granted: 2003-10-06
Abstract: The present invention relates to a female mammal contraceptive process consisting of the sequential administration for at least 28 days of (a) a gestagen in an ovulation-preventing dose for at least 28 days in combination with (b) a natural oestrogen for 5 to 10 days at the end of the sequential dosage of at least 28 days, and a contraception kit.